197 related articles for article (PubMed ID: 31843824)
1. Economic evaluation of clinical quality registries: a systematic review.
Lee P; Chin K; Liew D; Stub D; Brennan AL; Lefkovits J; Zomer E
BMJ Open; 2019 Dec; 9(12):e030984. PubMed ID: 31843824
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Melendez-Torres GJ; Auguste P; Armoiry X; Maheswaran H; Court R; Madan J; Kan A; Lin S; Counsell C; Patterson J; Rodrigues J; Ciccarelli O; Fraser H; Clarke A
Health Technol Assess; 2017 Sep; 21(52):1-352. PubMed ID: 28914229
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
4. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
5. Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis.
Lee P; Brennan AL; Stub D; Dinh DT; Lefkovits J; Reid CM; Zomer E; Liew D
BMJ Open; 2023 Apr; 13(4):e066106. PubMed ID: 37185178
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional study of characteristics of clinical registries in Australia: a resource for clinicians and policy makers.
Md Emdadul Hoque D; Ruseckaite R; Lorgelly P; McNeil JJ; Evans SM
Int J Qual Health Care; 2018 Apr; 30(3):192-199. PubMed ID: 29385457
[TBL] [Abstract][Full Text] [Related]
7. An Economic Evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry Program (ANZACS-QI 28).
Lee P; Zomer E; Liew D
Heart Lung Circ; 2020 Jul; 29(7):1046-1053. PubMed ID: 31537440
[TBL] [Abstract][Full Text] [Related]
8. Impact of clinical registries on quality of patient care and clinical outcomes: A systematic review.
Hoque DME; Kumari V; Hoque M; Ruseckaite R; Romero L; Evans SM
PLoS One; 2017; 12(9):e0183667. PubMed ID: 28886607
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
Frampton G; Harris P; Cooper K; Lotery A; Shepherd J
Health Technol Assess; 2014 Nov; 18(68):1-205, v-vi. PubMed ID: 25405576
[TBL] [Abstract][Full Text] [Related]
10. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
[TBL] [Abstract][Full Text] [Related]
11. The role of Australian clinical quality registries in pregnancy care: A scoping review.
Campion TSD; Daly JO; Wake M; Ahern S; Said JM
Aust N Z J Obstet Gynaecol; 2022 Aug; 62(4):472-482. PubMed ID: 35538882
[TBL] [Abstract][Full Text] [Related]
12. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
13. Identifying Existing Guidelines, Frameworks, Checklists, and Recommendations for Implementing Patient-Reported Outcome Measures: Protocol for a Scoping Review.
Jayasinghe RT; Ahern S; Maharaj AD; Romero L; Ruseckaite R
JMIR Res Protoc; 2024 May; 13():e52572. PubMed ID: 38771621
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
[TBL] [Abstract][Full Text] [Related]
15. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.
Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A
Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561
[TBL] [Abstract][Full Text] [Related]
17. Clinical quality registries: urgent reform is required to enable best practice and best care.
Brown WA; Ahern S; MacCormick AD; Reilly JR; Smith JA; Watters DA
ANZ J Surg; 2022 Jan; 92(1-2):23-26. PubMed ID: 35040551
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D
Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]